SAHAREK JOHN P. 4
4 · HARROW HEALTH, INC. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Exercise/Conversion
Common Stock
2022-02-19+50,000→ 80,000 total - Exercise/Conversion
Restricted Stock Unit
2022-02-19−50,000→ 0 totalExercise: $0.00→ Common Stock (50,000 underlying) - Tax Payment
Common Stock
2022-02-19$7.87/sh−25,923$204,014→ 54,077 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.